recombinant human protein C
Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation
8
Inhaled aerosolised recombinant human activated protein C ameliorates endotoxin induced lung injury in anaesthetised sheep
9
Recombinant human activated protein C for the treatment of severe sepsis and septic shock: a study protocol for incorporating observational evidence using a Bayesian approach
7
Recombinant human activated protein C resets thrombin generation in patients with severe sepsis – a case control study
8
Recombinant human activated protein C attenuates endotoxin induced lung injury in awake sheep
13
Original Article Prokaryotic expression of partial E gene of DENV strain and its effect on HUVEC permeability
8
Cell Surface Delivery of the Measles Virus Nucleoprotein: a Viral Strategy To Induce Immunosuppression
10
Pharmacogenomic biomarkers do not predict response to drotrecogin alfa in patients with severe sepsis
11
Microcirculatory alterations in ischemia–reperfusion injury and sepsis: effects of activated protein C and thrombin inhibition
5
Steroid use in PROWESS severe sepsis patients treated with drotrecogin alfa (activated)
6
A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C
6
Activated protein C ameliorates impaired renal microvascular oxygenation and sodium reabsorption in endotoxemic rats
11
Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin
7
Recombinant human activated protein C ameliorates oleic acid induced lung injury in awake sheep
8
Expression and Immunogenicity of Recombinant Immunoreactive Surface Protein 2 of Anaplasma phagocytophilum
5
Fibrinogen and Fibronectin Binding Activity and Immunogenic Nature of Choline Binding Protein M
8
Recombinant human activated protein C: current insights into its mechanism of action
6
The protein C pathway: implications for the design of the RESPOND study
7
The injury-induced myokine insulin-like 6 is protective in experimental autoimmune myositis
14
Interlaboratory Optimization and Evaluation of a Serological Assay for Diagnosis of Human Baylisascariasis
6